FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novartis Pharmaceuticals Ritalin HCl Recall

Ritalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per Bottle, Rx only, Mfd

Novartis Pharmaceuticals Corp. · Suffern, NY

Risk level
Class III
Reported by FDA
Apr 16, 2014
Recall ID
D-1227-2014
Check your lot numberHow we source this data

Summary

Novartis Pharmaceuticals recalled Ritalin HCl starting Mar 3, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1227-2014 on Apr 16, 2014. Reason: Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although t. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although t

Product description

Ritalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp. Suffern, NY 10901, Dist. by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC 0078-0440-05

Lot numbers, UPCs & expiration codes

Lot #: F0126

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1227-2014
Classification
Class III
Status
Terminated
Recall initiated
Mar 3, 2014
FDA report date
Apr 16, 2014
Quantity
10,930 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Novartis Pharmaceuticals Corp.

Original FDA data

Every field from FDA enforcement report D-1227-2014, exactly as published.

Show all FDA fields
City
Suffern
State
NY
Status
Terminated
Country
United States
Event ID
67633
Address
25 Old Mill Rd
Code information
Lot #: F0126
Postal code
10901-4106
Report date
Apr 16, 2014
Product type
Drugs
Recall number
D-1227-2014
Classification
Class III
Recalling firm
Novartis Pharmaceuticals Corp.
Product quantity
10,930 Bottles
Termination date
Dec 2, 2014
Reason for recall
Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although t
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ritalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp. Suffern, NY 10901, Dist. by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC 0078-0440-05
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Mar 3, 2014
Initial firm notification
Letter
Center classification date
Apr 8, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1227-2014, published Apr 16, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls